Novartis earnings and sales fall short of expectations, but backs 2022 view By: MarketWatch October 25, 2022 at 01:34 AM EDT The Swiss pharma major reported third-quarter net profit of $1.58 billion, on sales which declined to $12.54 billion. Read More >> Related Stocks: Novartis Ag ADR
